Lanean...
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Tumors responding to immune checkpoint inhibitors (ICIs) have a higher level of immune infiltrates and/or an Interferon (IFN) signature indicative of a T-cell-inflamed phenotype. Melanoma and lung cancer demonstrate high response rates to ICIs and are commonly referred to as “hot tumors”. These are...
Gorde:
| Argitaratua izan da: | J Immunother Cancer |
|---|---|
| Egile nagusia: | |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6307306/ https://ncbi.nlm.nih.gov/pubmed/30587233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0479-7 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|